150 related articles for article (PubMed ID: 11192367)
1. SB 203580, an inhibitor of p38 MAPK, abolishes infarct-limiting effect of ischemic preconditioning in isolated rabbit hearts.
Nakano A; Cohen MV; Critz S; Downey JM
Basic Res Cardiol; 2000 Dec; 95(6):466-71. PubMed ID: 11192367
[TBL] [Abstract][Full Text] [Related]
2. The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical.
Mocanu MM; Baxter GF; Yue Y; Critz SD; Yellon DM
Basic Res Cardiol; 2000 Dec; 95(6):472-8. PubMed ID: 11192368
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart.
Weinbrenner C; Liu GS; Cohen MV; Downey JM
J Mol Cell Cardiol; 1997 Sep; 29(9):2383-91. PubMed ID: 9299362
[TBL] [Abstract][Full Text] [Related]
5. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK.
Nakano A; Baines CP; Kim SO; Pelech SL; Downey JM; Cohen MV; Critz SD
Circ Res; 2000 Feb; 86(2):144-51. PubMed ID: 10666409
[TBL] [Abstract][Full Text] [Related]
6. p38 MAPK activity is not increased early during sustained coronary artery occlusion in preconditioned versus control rabbit heart.
Gysembergh A; Simkhovich BZ; Kloner RA; Przyklenk K
J Mol Cell Cardiol; 2001 Apr; 33(4):681-90. PubMed ID: 11273721
[TBL] [Abstract][Full Text] [Related]
7. Comparison between ischaemic and anisomycin-induced preconditioning: role of p38 MAPK.
Lochner A; Genade S; Hattingh S; Marais E; Huisamen B; Moolman JA
Cardiovasc Drugs Ther; 2003 May; 17(3):217-30. PubMed ID: 14574080
[TBL] [Abstract][Full Text] [Related]
8. SAPKs regulation of ischemic preconditioning.
Sato M; Cordis GA; Maulik N; Das DK
Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H901-7. PubMed ID: 10993748
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death.
Barancik M; Htun P; Strohm C; Kilian S; Schaper W
J Cardiovasc Pharmacol; 2000 Mar; 35(3):474-83. PubMed ID: 10710135
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of p38 MAPK alpha/beta reduces ischemic injury and does not block protective effects of preconditioning.
Schneider S; Chen W; Hou J; Steenbergen C; Murphy E
Am J Physiol Heart Circ Physiol; 2001 Feb; 280(2):H499-508. PubMed ID: 11158945
[TBL] [Abstract][Full Text] [Related]
11. The relative order of mK(ATP) channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart.
Yue Y; Qin Q; Cohen MV; Downey JM; Critz SD
Cardiovasc Res; 2002 Aug; 55(3):681-9. PubMed ID: 12160965
[TBL] [Abstract][Full Text] [Related]
12. SB 203580, a mitogen-activated protein kinase inhibitor, abolishes resistance to myocardial infarction induced by heat stress.
Joyeux M; Boumendjel A; Carroll R; Ribuot C; Godin-Ribuot D; Yellon DM
Cardiovasc Drugs Ther; 2000 Jun; 14(3):337-43. PubMed ID: 10935156
[TBL] [Abstract][Full Text] [Related]
13. Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart.
Baines CP; Wang L; Cohen MV; Downey JM
J Mol Cell Cardiol; 1998 Feb; 30(2):383-92. PubMed ID: 9515015
[TBL] [Abstract][Full Text] [Related]
14. Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion.
Marais E; Genade S; Huisamen B; Strijdom JG; Moolman JA; Lochner A
J Mol Cell Cardiol; 2001 Apr; 33(4):769-78. PubMed ID: 11273729
[TBL] [Abstract][Full Text] [Related]
15. Xanthine oxidase contributes to preconditioning's preservation of left ventricular developed pressure in isolated rat heart: developed pressure may not be an appropriate end-point for studies of preconditioning.
Gelpi RJ; Morales C; Cohen MV; Downey JM
Basic Res Cardiol; 2002 Jan; 97(1):40-6. PubMed ID: 11998976
[TBL] [Abstract][Full Text] [Related]
16. p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning.
Marais E; Genade S; Strijdom H; Moolman JA; Lochner A
J Mol Cell Cardiol; 2001 Dec; 33(12):2157-77. PubMed ID: 11735262
[TBL] [Abstract][Full Text] [Related]
17. Mast cell degranulation does not contribute to ischemic preconditioning in isolated rabbit hearts.
Wang P; Downey JM; Cohen MV
Basic Res Cardiol; 1996; 91(6):458-67. PubMed ID: 8996631
[TBL] [Abstract][Full Text] [Related]
18. Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart.
Sanada S; Kitakaze M; Papst PJ; Hatanaka K; Asanuma H; Aki T; Shinozaki Y; Ogita H; Node K; Takashima S; Asakura M; Yamada J; Fukushima T; Ogai A; Kuzuya T; Mori H; Terada N; Yoshida K; Hori M
Circ Res; 2001 Feb; 88(2):175-80. PubMed ID: 11157669
[TBL] [Abstract][Full Text] [Related]
19. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning.
Nakano A; Liu GS; Heusch G; Downey JM; Cohen MV
J Mol Cell Cardiol; 2000 Jul; 32(7):1159-67. PubMed ID: 10860760
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion.
Ma XL; Kumar S; Gao F; Louden CS; Lopez BL; Christopher TA; Wang C; Lee JC; Feuerstein GZ; Yue TL
Circulation; 1999 Apr; 99(13):1685-91. PubMed ID: 10190877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
